Navigation Links
Dr. Philip A. DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees
Date:6/11/2009

Chester Township scientist, author and lecturer lends his expertise to special ed school

MENDHAM TOWNSHIP, N.J., June 11 /PRNewswire-USNewswire/ -- Montgomery Academy's Board of Trustees voted unanimously during its May meeting to name Dr. Philip A. DeFina to the Board of the nonprofit, state approved school.

Dr. DeFina founded the nonprofit International Brain Research Foundation and serves as both its Chief Executive Officer and Chief Scientific Officer. He has been a Guest Researcher at the National Institute of Health and a member of the International Neuroscience Subcommittee of the World Health Organization. A pioneer in developing and directing clinical training programs in the cognitive neurosciences, Dr. DeFina has worked to develop groundbreaking treatments for traumatic brain injury, coma, Alzheimer's, autism and Parkinson's. DeFina, himself an Army veteran, has revived over forty patients from minimally conscious or vegetative states including five injured U.S. soldiers. He has worked in collaboration with the Department of Defense and is the chief consultant for the traumatic brain injury program at Kessler Institute for Rehabilitation. His treatment protocols include electronic brain stimulation and hyperbaric oxygen induction, among other therapies, to help balance the electrical and chemical activity in the brain.

"It is a great honor to have Phil join Montgomery Academy's Board," said J. Anthony Manger of Norris, McLaughlin & Marcus, P.A., who chairs the Board of Trustees and also serves as an officer of its Foundation. "Phil's powerful and cutting edge work in neuroscience and brain health makes him particularly well suited to guide this gem of a school as it enters its 40th year of service to classified and autistic students. We are absolutely thrilled that he's accepted our invitation to join the Board and look forward to partnering with him to promote his vitally important
'/>"/>

SOURCE Montgomery Academy Foundation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
2. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
3. Audio from Medialink and Philips: Americas Dirty Mouths
4. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
7. Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
8. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
9. Philip Coelho Joins Mediware Board
10. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
11. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Follow...market Company removed from sale Shedd,s Country C...ce and Shedd,s Country Crock ® Side Dishes DE...e allergen. ,, The following code dates and UP...4; Side Dishes DELUXE Cheddar Broccoli Rice 21 oz,...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewswire.... (CVSL.OB), http://www.CVSLMEDICAL.COM , a leadi...chnology, today announced that,the company,s Board...cations,in Europe, Canada and the Far East for its... applicable for all angioplasty (PCTA) procedures....
(Date:11/20/2009)... durations of exposure to formaldehyde used for em...th an increased risk of death from myeloid leukemi...ber 20 in the Journal of the National Cancer Inst...tality from lymphohematopoietic malignancies and b...al industry workers, all of whom may have worked w...
(Date:11/20/2009)...ers save up to one-third buying 90-day supply, stu...News) -- Buying a three-month supply of prescripti...one-month supply, according to a new study. , U...ed for 395 drugs between 2000 and 2005, and found ...ead of a one-month supply saved an average 29 perc...
(Date:11/20/2009)..., SPRINGFIELD, Mo., Nov. 20 Mis...entral Missouri regions will now have the option t... reached Tuesday between Missouri Consolidated Hea..., The Southwest and South Central Missouri regions...dar, Christian, Dade, Dallas, Douglas, Greene, Hic...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2
...or Global Business Travelers, RADNOR, Pa., Sept. ...ices company, today announced that HRG North Ameri...ner for mPassport(sm), HTH,s,new worldwide mobile ...racted English-speaking doctors, health and,safety...
...e Control and Prevention, the prevalence of childr...rn and greater interest in the disorder. Addressin... of Technology School of Psychology will host the ..., evidence-based information and feature noted aut...
...iagnose location of defects, study says , ...ue defects that contribute to hearing loss in chil...rs who analyzed the medical records of hundreds of...en used to look for bone structures problems in ch...
...plements maker Coromega today unveiled a new look ... single-dose packet that is clinically proven to d....1 Coromega’s packaging was redesigned to hi...ishy after-taste often experienced with capsules. ...
...ed Nurse Staffing in Hospitals, CHICAGO, Sept. 16...ort for state legislation that would increase the,...als. Speaking at a press,conference called by the ...al errors cause as many as 195,000 deaths a,year, ...
...pStart Inc., the,Northeast Ohio venture developmen...vative early-stage businesses and ideas, today ann...t of $380,000 in Freedom Meditech, Inc., a,develop...ology developed at the University of Toledo., (Lo...
Other Medicine News:Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 2Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 3Health News:Florida Tech autism conference, Oct. 3-4 2Health News:MRI Detects Soft Tissue Damage Affecting Kids' Hearing 2Health News: Coromega Hits Store Shelves with Fresh New Look : One-of-a-Kind Omega-3 Squeeze Packet Offers Same Superior Absorption with Mouth-Watering New Packaging Design 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 3Health News:Freedom Meditech Receives JumpStart Investment 2Health News:Freedom Meditech Receives JumpStart Investment 3
(Date:11/20/2009)... In response to a recent...ntly available medications designed to treat and p...ute, an independent nonprofit organization, is off...r Prevention of Prostate Cancer for free downloa...article, " Drugs to Deter Some Cancers Are Not Tak...
(Date:11/19/2009)...swire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.... public offering of 5,000,000 shares of its common...eeds of $48.75 million. All of the shares are bei...elf registration statement previously filed with t...as also granted the underwriters a 30-day option t...
(Date:11/19/2009)...-- Riverain Medical announced today that the compa...l imaging distributor Christie Group to offer Soft... CAD. The exclusive agreement will bring Dayton, O...ian market through Christie Group,s established an... Chest Imaging increases the clarity of digital ch...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Go Go Goji 21 UNO 28R 29 Fall Menu Is Berry Delicious 60101 1Go Go Goji 21 UNO 28R 29 Fall Menu Is Berry Delicious 60101 2Go Go Goji 21 UNO 28R 29 Fall Menu Is Berry Delicious 60101 3Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 1Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 2Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 3Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 4Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 1Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 2Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 3Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 4Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 5
...21, 2007/PRNewswire-FirstCall/ -- Bristol-Myers,Sq...from study,ETV-079, which showed that treatment wi...l load reduction than adefovir at 48 weeks,-- a re...int) and,24. These data from an open-label, random...ronic hepatitis B e-antigen (HBeAg),positive patie...
...ability to limit inflammation in models of,arthrit...sented at,Digestive Disease Week -, WASHINGTON, Ma...ny Alimentary Health today announced results from ... activity of a natural,probiotic bacterial strain ...ntis 35624), in models of arthritis and,Salmonella...
Other Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory,Properties and Increased Health Benefits 2New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory,Properties and Increased Health Benefits 3
S.O.B Medium without Magnesium
S.O.C. Medium
rHead Radial Implant System
Swanson Titanium Radial Head Implants
Medicine Products: